Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: A randomised parallel trial

Lancet

Volumn 359, Issue 9302, 2002, Pages 204-210

  Pepperell, Justin C T ^a   Ramdassingh Dow, Sharon ^a   Crosthwaite, Nicky ^a   Mullins, Rebecca ^a   Jenkinson, Crispin ^a   Stradling, John R ^a   Davies, Robert J O ^a  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; SCORING SYSTEM; SLEEP APNEA SYNDROME; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; WAKEFULNESS;

EID: 0037132846     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)07445-7     Document Type: Article

References (42)

1. The occurrence of sleep-disordered breathing among middle-aged adults
2. A community study of snoring and sleep-disordered breathing: Prevalence
3. Prevalence of sleepiness and its relation to autonomic evidence of arousals and increased inspiratory effort in a community based population of men and women
4. Prospective study of the association between sleep-disordered breathing and hypertension
5. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study
6. Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnoea and normal matched control subjects
7. Sleep-disordered breathing and cardiovascular disease: Cross-sectional results of the Sleep Heart Health study
8. Effect of nasal continuous positive airway pressure during sleep on 24-hour blood pressure in obstructive sleep apnea
9. Daytime hypertension and the effects of short-term nasal continuous positive airway pressure treatment in obstructive sleep apnea syndrome
10. Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome
11. Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: A systematic review of the research evidence
12. The relationship between systemic hypertension and obstructive sleep apnea: Facts and theory
13. Sleep apnea-A major public health problem
14. Deep and shallow truths
15. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: A randomised prospective parallel trial
16. A new method for measuring daytime sleepiness: The Epworth sleepiness scale
17. Sleep fragmentation indices as predictors of daytime sleepiness and nCPAP response in OSA
18. Differentiating obstructive and central sleep respiratory events through pulse transit time
19. Accuracy of the Takeda TM-2420/TM-2020 determined by the British Hypertension Society protocol
20. Use and interpretation of ambulatory blood pressure monitoring: Recommendations of the British Hypertension Society
21. A behavioural test to assess daytime sleepiness in obstructive sleep apnoea
22. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias
23. Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome
24. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: Overview of randomised drug trials in the epidemiological context
25. Identification of sleep disruption and sleep disordered breathing from the systolic blood pressure profile
26. Blood pressure "dipping" and "non-dipping" in obstructive sleep apnea syndrome patients
27. Strategies for the evaluation and treatment of hypertension and some implications of blood pressure variability
28. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension
29. Clinical relevance blood pressure variability
30. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome
31. Catecholamines and blood pressure in obstructive sleep apnea syndrome
32. Cardiac arrhythmias and conduction disturbances during sleep in 400 patients with sleep apnea syndrome
33. Beta-blockade during and after myocardial infarction: An overview of the randomised trials
34. Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome
35. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model
36. Relationships between changes in left ventricular mass and in clinic and ambulatory blood pressure in response to antihypertensive therapy
37. Risk stratification of left ventricular hypertrophy in systemic hypertension using noninvasive ambulatory blood pressure monitoring
38. Prognostic value of ambulatory blood pressure current evidence and clinical implications
39. Arousal and the circadian rhythm of blood pressure
40. Long-term nasal continuous positive airway pressure administration can normalize hypertension in obstructive sleep apnea patients
41. Blood pressure and sleep apnoea: Results of long-term nasal continuous positive airways pressure therapy
42. Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: Cardiovascular implications